I'm shifting focus to high-quality preferred stocks, especially GDV.PR.K and GDV.PR.H, as common stocks appear overvalued.

Media and entertainment conglomerate Disney (NYSE:DIS) saw strong momentum in its entertainment direct-to-consumer segment ...

Shares of Astec Industries ( NASDAQ: ASTE) surged 17% in premarket trading Wednesday after the company posted a sharp ...

Ominicom's ( NYSE: OMC) planned $13 billion purchase of rival Interpublic ( NYSE: IPG) received approval from the UK's ...

Parsons’ net income dropped 20% year-over-year to $55 million, with earnings slipping to $0.50 a share from $0.63 a year ...

W.P. Carey (WPC) remains a quality REIT with a strong 5.54% yield and recent dividend raises, but I'd prefer a lower addon ...

MannKind (MNKD) and funds managed by Blackstone (BX) on Wednesday said that they have entered into an up to $500 million strategic financing agreement.

Teva (TEVA) stock in focus as the FDA expands label for its migraine therapy Ajovy for children and adolescents aged 6–17 years. Read more here.

Palantir's stock price surge seems puzzling given its stretched valuation. Read why PLTR stock's valuation continues to front ...

Centerspace offers a compelling setup for income and value investors, with a well-covered 5.7% dividend yield and a forward P ...

The company entered into an equity distribution agreement, pursuant to which it may sell shares of its Class C common stock from time to time through agents. Sales of the shares, if any, will ...

ORIC's pipeline shows early promise, especially ORIC-944 in prostate cancer. Well-funded through 2027, but safety risks ...